Oxford Bioscience raises its sixth fund
Oxford Bioscience Partners is back. The investment outfit has held a $66 million first close on its sixth fund, which targets between $100 million and $150 million. A chunk of that money came from the South Korean government, which is looking to promote biotech investment in the country. Report
Comments